logo

Morphosys Ag (MOR)



Trade MOR now with
  Date
  Headline
8/3/2022 4:11:03 PM MorphoSys AG Q2 Earnings Summary
7/26/2022 6:16:52 AM MorphoSys Preliminary Q2 Monjuvi U.S. Net Product Sales $23.3 Mln/EUR 21.7 Mln
6/15/2022 8:43:08 AM I-Mab Partner MorphoSys Announces License Agreements For Felzartamab And TJ210
6/14/2022 4:09:51 PM MorphoSys And HIBio Enter Into Equity Participation And License Agreements For Felzartamab And MOR210
6/10/2022 3:30:46 AM MorphoSys Presents Data From Multiple Analyses Of MANIFEST Study
5/4/2022 4:13:59 PM MorphoSys AG Q1 Loss/share EUR 3.59 Vs. Loss EUR 1.27 Year Ago
5/4/2022 4:09:17 PM MorphoSys AG Q1 Loss Climbs
3/16/2022 4:12:50 PM MorphoSys AG Q4 Loss Rises
3/16/2022 4:11:55 PM MorphoSys Q4 Loss/share EUR 11.16 Vs. Loss EUR 0.50 Year Ago
1/7/2022 2:19:31 AM MorphoSys Posts Preliminary 2021 Monjuvi U.S. Net Product Sales Of $79.1 Mln